Gene Therapy
Overview
Gene Therapy is a peer-reviewed scientific journal that focuses on the latest advancements in the field of gene therapy. It publishes original research articles, reviews, and commentaries, covering topics such as gene delivery systems, gene editing technologies, and clinical applications of gene therapy. With a multidisciplinary approach, the journal serves as a valuable resource for researchers, clinicians, and students interested in understanding and harnessing the potential of gene therapy for treating genetic disorders and other diseases.
Details
Details
Abbr.
Gene Ther
Start
1994
End
Continuing
Frequency
Monthly, 2009-
p-ISSN
0969-7128
e-ISSN
1476-5462
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 1016
174
SJR / Ranks: 1619
1671
CiteScore / Ranks: 1970
8.60
JIF / Ranks: 1521
5.1
Recent Articles
1.
2.
Solodushko V, Kim J, Fouty B
Gene Ther
. 2025 Feb;
PMID: 39988620
The success of mRNA vaccines in controlling the COVID 19 pandemic has confirmed the efficacy of synthetically synthesized mRNA in humans and has also provided a blueprint on how to...
3.
Tong L, Ozes B, Moss K, Myers M, Attia Z, Vetter T, et al.
Gene Ther
. 2025 Feb;
PMID: 39972161
Multiple sclerosis (MS) is an immune-mediated chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) affecting more than 2.5 million patients worldwide. Chronic demyelination in the CNS has...
4.
Tang X, Wang H, Yin Y, Zhong G
Gene Ther
. 2025 Feb;
PMID: 39939797
Genetic switches that allow for precise control over transgene expression timing or levels may improve the safety and expand the use of adeno-associated viral (AAV) vector-based gene therapy technologies. We...
5.
Gumusgoz E, Kasiri S, Youssef I, Verma M, Chopra R, Villarreal Acha D, et al.
Gene Ther
. 2025 Feb;
PMID: 39893321
Because children have little temporal exposure to environment and aging, most pediatric neurological diseases are inherent, i.e. genetic. Since postnatal neurons and astrocytes are mostly non-replicating, gene therapy and genome...
6.
7.
Pichard V, Guilbaud M, Devaux M, Jaulin N, Journou M, Cospolite M, et al.
Gene Ther
. 2025 Jan;
PMID: 39838066
The liver is a unique organ where immunity can be biased toward ineffective response notably in the context of viral infections. Chronic viral hepatitis depends on the inability of the...
8.
Zhou K, Yuan M, Sun J, Zhang F, Li X, Xiao X, et al.
Gene Ther
. 2025 Jan;
PMID: 39833570
Osteoarthritis (OA), a prevalent joint disorder, can lead to disability, with no effective treatment available. Interleukin-1 (IL-1) plays a crucial role in the progression of OA, and its receptor antagonist...
9.
Cao M, Katial R, Liu Y, Lu X, Gu Q, Chen C, et al.
Gene Ther
. 2025 Jan;
PMID: 39825100
The approved intravenous adeno-associated virus (AAV) therapies are limited by the widespread prevalence of pre-existing anti-AAV antibodies in the general population, which are known to restrict patients' ability to receive...
10.
Pant D, Verma S
Gene Ther
. 2025 Jan;
PMID: 39794476
Spinal muscular atrophy (SMA) is a progressive disease that affects motor neurons, with symptoms usually starting in infancy or early childhood. Recent breakthroughs in treatments targeting SMA have improved both...